In particular, the numbers of circulating classical monocytes (CD14++CD16−) decrease, but the numbers of intermediate (CD14++CD16+) and non-classical (CD14+CD16++) monocytes increase in COVID-19 patients. The gene discussed is CD14; the disease is COVID-19.